Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. - Wikidata - thesis-toulmin - TriplyDB

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

http://www.wikidata.org/entity/Q34341727

about

Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities.Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.MicroRNAs: novel players in cancer diagnosis and therapies.Far beyond the usual biomarkers in breast cancer: a review.Lin28B is a novel prognostic marker in gastric adenocarcinoma.MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling.Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer.Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells.Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.The relationship between Lin28 and the chemotherapy response of gastric cancer Clinicopathological Characteristics of Patients with Gastric Cancer according to the Expression of LIN28A.Multidrug-resistant breast cancer: current perspectives.The LIN28/let-7 Pathway in Cancer.Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancer The mystery of let-7d - a small RNA with great power.Lin28: an emerging important oncogene connecting several aspects of cancer.Updates on the Molecular Pathology of Selected Ocular and Ocular Adnexal Tumors: Potential Targets for Future Therapy.PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer.Mcl-1 stabilization confers resistance to taxol in human gastric cancer.Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer.Lin28A enhances chemosensitivity of colon cancer cells to 5-FU by promoting apoptosis in a let-7 independent manner.MLN4924 neddylation inhibitor promotes cell death in paclitaxel-resistant human lung adenocarcinoma cells.Differential Regulation of LET-7 by LIN28B Isoform-specific Functions.Positive expression of Lin28 is correlated with poor survival in gastric carcinoma.Oncogene Lin28B increases chemosensitivity of colon cancer cells in a let-7-independent manner.The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer.

P2860

Q33649015-189D1D67-7F25-44A2-9DBB-F17E7CF4B88F Q33838622-3D8E0340-B49D-441C-82C4-E24AFBBE3274 Q33914573-4126048A-267B-470F-8018-DB800B7D7D51 Q33935217-2C91C88F-D44D-4D84-873A-15A419A238F2 Q34121523-6D85CA6E-0428-4024-BFE7-34E8EF47948E Q34154782-E7C42905-F4BC-44BF-AC4F-7B06BB0327B9 Q34807238-59E9EFAC-F42E-41C6-BACE-35DBCBA64380 Q35048886-417A5EFD-06E1-4331-89BE-568B4AA03D4F Q35070771-45B506C7-E539-4D26-B488-D3A88E5A580A Q35860856-AA7E834B-BBA3-4B72-A339-281BB0564ACA Q35963802-2EDC97FC-E4D8-442C-842F-4E84716BD55B Q35988876-FCE23660-6DFC-4CDA-A0B2-D1C763B92B1D Q37213326-06B72580-CC3D-49A5-B3C1-21F6E2924F87 Q37213507-0D73293E-E3C7-4EA9-8731-8857BFAF5A68 Q37593383-CC78255D-94F4-4ECD-9F01-1C5E088749C1 Q37723361-28D86CAD-03F9-4FD9-8BD8-DD37B78A85DC Q37736667-8FCA4B44-31D5-470A-BD91-86CDC66A73C8 Q38239141-61FB4045-EFCB-4FCC-8F78-0BCF8E76B083 Q38283518-FC2046E2-5DAF-4BF8-A139-BCF4D1D605D3 Q38695098-696C48D9-8319-47E6-89FF-F26C259BDCF3 Q38766864-1974E5C7-9133-4C3C-838A-163E550EA25A Q39067495-86E9FDD4-E2E5-423C-B600-C1211E332DAA Q43637703-004A6F1E-4137-4451-8621-BE720B511D81 Q45241774-AFF7C3DF-3621-47EB-9C38-211E2090437A Q48277392-88F3F9EA-8F45-4BE1-8682-7C7142C8D991 Q48517497-FF143C69-64DD-4EDD-935B-229F09B3A5A2 Q50059044-5863A459-06F3-415D-9D5B-91579847387B Q54276992-3C384693-7217-4643-8242-B1660F7933BB Q55027107-1E13C4BB-3560-436D-8CF1-AA7534545F22 Q55717664-D14BA45A-EB31-47EC-995D-54CC2E6FFD83

P2860

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

http://www.wikidata.org/entity/Q34341727

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@ast

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@en

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@nl

type

label

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@ast

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@en

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@nl

prefLabel

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@ast

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@en

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@nl

P1433

Q34341727-DA1BB461-06E3-43F2-B788-652436B23B32

P1476

Q34341727-CBF8E0AF-7AFC-4C3E-9C6F-4B61FF49F0BF

P2093

Q34341727-081D6B12-DEB4-4284-917E-61B2543C2508

Q34341727-21D6776D-9C57-4B2F-8295-CFEDAE58FEE4

Q34341727-241EFD3E-3213-47C0-B7D9-A9AB8F635ADE

Q34341727-440AD90D-B8AB-4EEB-A695-3264A559DD61

Q34341727-4BF8550C-FD88-4DC3-92A5-EC40F93E528D

Q34341727-8AE107AB-E145-459A-8046-CFAB6016C2E1

Q34341727-9CC2A055-E055-451E-8626-6C0FA1420A48

Q34341727-9F33C4DC-CE27-494A-9176-195A8F1D4CA2

Q34341727-AFFC2911-9376-40D5-9BA3-615B0ABAA6FD

Q34341727-BF7CF747-E8AD-4CE4-9254-9F6CC7654BD8

P2860

Q34341727-11084189-3C16-4C53-A645-6ABB5EA2C574

Q34341727-157D4EEF-57AB-443D-863C-F74A28CBD815

Q34341727-230DC246-72DD-4559-95A5-5F8F599CBEFA

Q34341727-3AD1D5B3-6E59-4CB6-BD3D-E59AAA15BCB8

Q34341727-5AA71A71-93EF-4290-830B-41B4BA1ABD8B

Q34341727-6A32D0F1-7278-4031-B177-4AD7D0719889

Q34341727-710CA197-8093-4E7E-82DB-F0F7ED22E3FF

Q34341727-7F015F72-BEB0-423D-8EB1-56F554031F83

Q34341727-8C374513-6E13-470B-B7FB-8682B09EF614

Q34341727-B0B709CA-CF9E-4A8C-B4CE-37F3D6B94612

P304

Q34341727-0A8F333D-212C-49C1-A63C-36ED25B93991

P31

Q34341727-C47DC740-BD30-4E72-9783-2F2CD6B32359

P356

Q34341727-C375ADA9-61C2-44CB-A661-8AEDE669D210

P407

Q34341727-47893D09-58FC-4B1D-9439-177725C4F613

P433

Q34341727-5D98F67F-1B34-4A8E-A6AF-E9869A007E48

P478

Q34341727-FA1CAB26-8E72-435A-A28A-70C6B9B9D4B4

P577

Q34341727-26FF47ED-183F-4487-A549-C0BE9FE4CEC0

P5875

Q34341727-E9EB67DD-AAE0-48F2-8F66-D38FAE7B2F76

P698

Q34341727-033AB3E8-8228-4F47-9CEF-69A5328E95BC

P932

Q34341727-D273FDA7-4D8C-4FFC-8E47-A20F9C34EF8E

P356

JOURNAL.PONE.0040008

P1433

P1476

Lin28 mediates paclitaxel resi ...... miRNA in breast cancer cells.

@en

P2093

Jiren Yu

http://www.w3.org/2001/XMLSchema#string

Kezhen Lv

http://www.w3.org/2001/XMLSchema#string

Linbo Wang

http://www.w3.org/2001/XMLSchema#string

Linjiao Wu

http://www.w3.org/2001/XMLSchema#string

Liqun Liu

http://www.w3.org/2001/XMLSchema#string

Lisong Teng

http://www.w3.org/2001/XMLSchema#string

Minjun Dong

http://www.w3.org/2001/XMLSchema#string

Peifen Fu

http://www.w3.org/2001/XMLSchema#string

Rongyue Teng

http://www.w3.org/2001/XMLSchema#string

Wenxian Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA

Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells

Selective blockade of microRNA processing by Lin28

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

RAS is regulated by the let-7 microRNA family

Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer.

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells.

p53, BRCA1 and breast Cancer chemoresistance.

Cancer stem cells: the emerging challenge of drug targeting.

P304

e40008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0040008

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229162132

http://www.w3.org/2001/XMLSchema#string

P698

22808086

http://www.w3.org/2001/XMLSchema#string

P932

3392258

http://www.w3.org/2001/XMLSchema#string